Back
ESC Professional Premium Access

High discontinuation rate of statins among PCSK9i users: a nationwide study from 2015-2023

Session: Lifestyle, obesity, and dyslipidaemia
Topic: Drug therapy
Speaker: Ms I. Engebretsen (Oslo, NO)
Event: ESC Congress 2024

Congress Presentation

Add to my library

Like

About the speaker

Ms Ingrid Engebretsen

Oslo Economics, Oslo (Norway)
0 follower

4 more presentations in this session

The impact of pre-myocardial infarction exercise frequency on prognosis in acute myocardial infarction patients

Speaker: Doctor T. Gu (Tianjin, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Revisiting the obesity paradox: lean body mass, fat mass, and mortality in patients with atrial fibrillation

Speaker: Professor Y. Lu (Shanghai, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Association between achieved cholesterol levels and the risk of major adverse cardiovascular events after acute coronary syndromes

Speaker: Mr C. Follonier (Geneva, CH)

Access
Abstract
Slides
Video
Like
Thumbnail

Comparing PCSK9 inhibitor prescription rates within high-risk populations: diabetes mellitus, multi-territory vascular disease, multivessel and recurrent coronary artery disease

Speaker: Doctor W. He (Melbourne, AU)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Lifestyle, obesity, and dyslipidaemia

Speakers: Ms I. Engebretsen, Doctor T. Gu, Professor Y. Lu, Mr C. Follonier, Doctor W. He
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources